GE Healthcare announced Monday a brand new artificial intelligence application that may save time for doctors diagnosing and treating cancer.
CareIntellect for Oncology, because the tool known as, will help oncologists stay informed a few patient's medical history and disease progression by quickly showing them the information they need, the corporate said. GE HealthCare wants to save lots of oncologists the trouble of digging through paperwork so that they can concentrate on caring for his or her patients, the corporate says.
Healthcare data is notoriously difficult to research and as much as 97% of knowledge produced by hospitals goes unused, a study suggests Deloitte Report. This information is stored across multiple vendors and in file formats corresponding to images, lab test results, clinical notes, and device readings, which will be extremely stressful for physicians to sort through.
“It's very time consuming and very frustrating for these clinicians,” said Dr. Taha Kass-Hout, Global Chief Science and Technology Officer of GE HealthCare, in an interview with CNBC.
CareIntellect for Oncology will have the option to summarize clinical reports and discover when patients are deviating from their treatment plans, Kass-Hout said. For example, the system can report if a patient misses a lab test so their doctor can determine the very best next steps.
“For cancer patients, the treatment journey can take years and require numerous doctor visits,” he said.
“CareIntellect for Oncology can also help identify relevant clinical trials for which patients may be eligible, saving oncologists hours,” said Chelsea Vane, vice chairman of digital products at GE HealthCare. This process traditionally required doctors to go looking through a database of accessible studies, memorize inclusion and exclusion criteria, and search through patient records to find out an excellent fit, Vane told CNBC.
“What we’ve done is removed that,” she said.
The purpose of the brand new app is to save lots of oncologists effort and time. However, if doctors wish to delve deeper, CareIntellect for Oncology allows them to view the unique referenced record, the corporate said.
GE HealthCare plans to make CareIntellect for Oncology widely available to U.S. customers in 2025, initially optimizing it for prostate and breast cancer. Healthcare organizations like Tampa General Hospital are already looking into it, the corporate said. Because the tool is cloud-based, it’ll increase GE HealthCare's recurring revenue, Kass-Hout said.
The company plans to introduce more apps under the CareIntellect brand in the longer term, Kass-Hout said. The oncology tool is the primary offering, and healthcare organizations can easily select the apps they wish to enable, he added.
GE HealthCare also hopes to integrate its CareIntellect products with a few of the other early-stage AI initiatives it announced Monday.
The company unveiled five latest AI products it’s developing, including a collaborative team of AI agents, a tool to predict an aggressive variety of breast cancer reoccurrence, and a tool to more quickly report suspicious mammography scans to radiologists.
GE HealthCare decided to preview the brand new tools to present customers a way of the issues the corporate is trying to unravel, Kass-Hout said. The company will seek feedback from healthcare organizations and work with regulators as needed, he said.
GE HealthCare, for instance, is exploring how a gaggle of AI agents can work together as a team to support doctors through its tool called Health Companion.
Health Companion agents are trained to be experts in specific areas corresponding to radiology, pathology or genomics and supply insight based on their expertise, Kass-Hout said. For example, agents can discover whether a selected symptom is a side effect of treatment or an indication of disease progression and suggest further steps, he added.
Ideally, the tool would supply physicians with the identical variety of support they’d expect when working with a multidisciplinary team, Kass-Hout said. While consultation with a panel of experts can take days or perhaps weeks, Health Companion could be available immediately.
“Right now it’s an early concept,” he said. “Our goal is to raise the standard of care and stay one step ahead of the overload of physicians trying to care for their patients.”
REGARD: The pulse of AI in healthcare
image credit : www.cnbc.com